Strengths and Uncertainties of the Screening Analysis Sample Clauses

Strengths and Uncertainties of the Screening Analysis. The primary strength of the analysis described above is its conservative approach and assumption that screened chemicals will be emitted at the full limit of the relevant PSEL or higher in the case of non-HAPs if the predicted emission rate is greater than 10 tons per year. The likely over-prediction of concentrations from the SCREEN3 model and likely under-prediction of safe health risk levels by the AAAQG methodology make the screening analysis a valuable tool in providing additional assurance that air emissions at the Ocotillo Site do not pose a special risk to employees, visitors or the community. The precautionary principle states that in the face of uncertainty, additional safety factors should be applied to the analysis. In the analysis described above, several safety factors have been applied but, as with all simulations of the real world, not every scenario can be anticipated. For example, synergistic effects (i.e., when exposure to a combination of chemicals is more hazardous than exposure to any single chemical) or antagonistic effects (i.e., when chemical combinations are less hazardous than the individual chemicals) are not understood by today's science. In addition, unanticipated dispersion events cannot be adequately predicted by simulation models. Finally, the potential reaction of some sensitive subgroups within the population may not always be fully accounted for by the additional layers of safety factors. INTEL AIR EMISSIONS SCREENING MODEL Model Used: U.S. EPA SCREEN 3 (1991-1996, Trinity Consultants Inc. Version 1.0) AZ Agency: Maricopa County Environmental Services Department Duration used by MCESD: XXXXX has used this model since 1990 Model Type: Gaussian model Model Application: Continuous emissions vs. episodic event Model Purpose: Conservative model to help compare emissions to AZ Ambient Air Quality Guidelines to ensure public health is protected Intel Assumptions in Running the SCREEN 3 Model: • SCREEN 3 model with the following conditions; SITE: Rural terrain SOURCE: - Point Source - Distance to property line, 479 m - Emission rate, 0.288 g/s - Stack height, 31.2 m - Stack I.D., 1.56 m - Stack Velocity 15 m/s - Temperature 273º K DOWNDRAFT: Bldg. dimensions; L/W/H, 700'/425'/80' or 219m/133m/25m FUMIGATION: Inversion Break-up (Rural only) METEOROLOGY: Full meteorology • Operation 24 hours/day - 365 days/year • Emission point at one scrubber vs. seven scrubbers (one is more conservative) • Model @ 10 Tons per year routine releas...
AutoNDA by SimpleDocs

Related to Strengths and Uncertainties of the Screening Analysis

  • Disturbance Analysis Data Exchange The Parties will cooperate with one another and the NYISO in the analysis of disturbances to either the Large Generating Facility or the New York State Transmission System by gathering and providing access to any information relating to any disturbance, including information from disturbance recording equipment, protective relay targets, breaker operations and sequence of events records, and any disturbance information required by Good Utility Practice.

  • Geological and Archeological Specimens If, during the execution of the Work, the Contractor, any Subcontractor, or any servant, employee, or agent of either should uncover any valuable material or materials, such as, but not limited to, treasure trove, geological specimens, archival material, archeological specimens, or ore, the Contractor acknowledges that title to the foregoing is vested in the Owner. The Contractor shall notify the Owner upon the discovery of any of the foregoing, shall take reasonable steps to safeguard it, and seek further instruction from the Design Professional. Any additional cost incurred by the Contractor shall be addressed under the provision for changed conditions. The Contractor agrees that the Geological and Water Resources Division and the Historic Preservation Division of the Georgia Department of Natural Resources may inspect the Work at reasonable times.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • GEOGRAPHIC AREA AND SECTOR SPECIFIC ALLOWANCES, CONDITIONS AND EXCEPTIONS The following allowances and conditions shall apply where relevant: Where the company does work which falls under the following headings, the company agrees to pay and observe the relevant respective conditions and/or exceptions set out below in each case.

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Vaccination and Inoculation (a) The Employer agrees to take all reasonable precautions, including in-service seminars, to limit the spread of infectious diseases among employees.

  • Feasibility Each of the Project Budget, the Project Schedule and the Disbursement Schedule is realistic and feasible.

  • Technical Feasibility of String While ICANN has encouraged and will continue to encourage universal acceptance of all top-­‐level domain strings across the Internet, certain top-­‐level domain strings may encounter difficulty in acceptance by ISPs and webhosters and/or validation by web applications. Registry Operator shall be responsible for ensuring to its satisfaction the technical feasibility of the TLD string prior to entering into this Agreement.

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK Firms and/or individuals that assisted in the development or drafting of the specifications, requirements, statements of work, or solicitation documents contained herein are excluded from competing for this solicitation. This shall not be applicable to firms and/or individuals providing responses to a publicly posted Request for Information (RFI) associated with a solicitation.

  • Musculoskeletal Injury Prevention and Control (a) The Hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

Time is Money Join Law Insider Premium to draft better contracts faster.